Authors:
WIERNIK PH
DUTCHER JP
EINZIG AI
SPARANO J
FRANK M
FRIEDENBERG W
Citation: Ph. Wiernik et al., MITOXANTRONE, VINBLASTINE, AND LOMUSTINE (CCNU) (MVC) - A HIGHLY-ACTIVE REGIMEN FOR ADVANCED AND POOR-PROGNOSIS HODGKINS-DISEASE, The cancer journal from Scientific American, 4(4), 1998, pp. 254-260
Authors:
EINZIG AI
WIERNIK PH
WADLER S
KAPLAN J
BENSON LT
TENTORAMANO L
TAN V
Citation: Ai. Einzig et al., PHASE-I STUDY OF PACLITAXEL (TAXOL) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN PATIENTS WITH UNRESECTABLE MALIGNANCY, Investigational new drugs, 16(1), 1998, pp. 29-36
Authors:
SKLARIN NT
LATHIA CD
BENSON L
GROVE WR
THOMAS S
ROCA J
EINZIG AI
WIERNIK PH
Citation: Nt. Sklarin et al., A PHASE-I TRIAL AND PHARMACOKINETIC EVALUATION OF CI-980 IN PATIENTS WITH ADVANCED SOLID TUMORS, Investigational new drugs, 15(3), 1997, pp. 235-246
Authors:
EINZIG AI
NEUBERG D
REMICK SC
KARP DD
ODWYER PJ
STEWART JA
BENSON AB
Citation: Ai. Einzig et al., PHASE-II TRIAL OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH ADENOCARCINOMA OF THE UPPER GASTROINTESTINAL-TRACT PREVIOUSLY UNTREATED WITH CYTOTOXIC CHEMOTHERAPY - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) RESULTS OF PROTOCOL E1293, Medical oncology, 13(2), 1996, pp. 87-93
Authors:
EINZIG AI
SCHUCHTER LM
RECIO A
COATSWORTH S
RODRIQUEZ R
WIERNIK PH
Citation: Ai. Einzig et al., PHASE-II TRIAL OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH METASTATIC MELANOMA PREVIOUSLY UNTREATED WITH CYTOTOXIC CHEMOTHERAPY, Medical oncology, 13(2), 1996, pp. 111-117
Citation: Ai. Einzig et al., LIFE-THREATENING HYPERLEUKOCYTOSIS AND PULMONARY COMPROMISE AFTER PRIMING WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN A PATIENT WITH ACUTE MYELOMONOCYTIC LEUKEMIA, Journal of clinical oncology, 13(1), 1995, pp. 304-305
Citation: Ai. Einzig et al., PHASE-II TRIAL OF TAXOL IN PATIENTS WITH ADENOCARCINOMA OF THE UPPER GASTROINTESTINAL-TRACT (UGIT) - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP(ECOG) RESULTS, Investigational new drugs, 13(3), 1995, pp. 223-227
Citation: Ai. Einzig, PACLITAXEL (TAXOL(R)) FOR THE TREATMENT OF ADVANCED OVARIAN-CANCER - REVIEW OF PHASE-II TRIALS, International journal of gynecological cancer, 4, 1994, pp. 3-6
Citation: Jg. Kaplan et al., TAXOL CAUSES PERMANENT LARGE FIBER PERIPHERAL-NERVE DYSFUNCTION - A LESSON FOR PREVENTATIVE STRATEGIES, Journal of neuro-oncology, 16(2), 1993, pp. 105-107